These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 19195429

  • 1. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M.
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [Abstract] [Full Text] [Related]

  • 2. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 3. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ.
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [Abstract] [Full Text] [Related]

  • 4. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B.
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [Abstract] [Full Text] [Related]

  • 5. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
    Downey LA, Sands H, Jones L, Clow A, Evans P, Stalder T, Parrott AC.
    Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
    [Abstract] [Full Text] [Related]

  • 6. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC, Parrott AC, Turner JJ.
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [Abstract] [Full Text] [Related]

  • 7. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Taurah L, Chandler C, Sanders G.
    Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
    [Abstract] [Full Text] [Related]

  • 8. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K, Turner JJ, Parrott AC.
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [Abstract] [Full Text] [Related]

  • 11. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
    Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A.
    Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
    [Abstract] [Full Text] [Related]

  • 12. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
    Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K.
    J Psychopharmacol; 1998 Apr; 12(1):79-83. PubMed ID: 9584971
    [Abstract] [Full Text] [Related]

  • 13. Cognitive performance amongst recreational users of "ecstasy".
    Rodgers J.
    Psychopharmacology (Berl); 2000 Jul; 151(1):19-24. PubMed ID: 10958112
    [Abstract] [Full Text] [Related]

  • 14. Discrete memory impairments in largely pure chronic users of MDMA.
    Wunderli MD, Vonmoos M, Fürst M, Schädelin K, Kraemer T, Baumgartner MR, Seifritz E, Quednow BB.
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005
    [Abstract] [Full Text] [Related]

  • 15. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F, Piechatzek M, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, Lange KW, Wittchen HU, Schütz CG.
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [Abstract] [Full Text] [Related]

  • 16. Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.
    de Sola S, Tarancón T, Peña-Casanova J, Espadaler JM, Langohr K, Poudevida S, Farré M, Verdejo-García A, de la Torre R.
    Psychopharmacology (Berl); 2008 Oct; 200(3):425-37. PubMed ID: 18581098
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC, Lasky J.
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [Abstract] [Full Text] [Related]

  • 20. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.
    Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC.
    J Psychopharmacol; 2003 Dec; 17(4):389-96. PubMed ID: 14870950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.